Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) EBIT: 2019-2024

Historic EBIT for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to -$320.7 million.

  • P3 Health Partners' EBIT rose 5866.62% to -$44.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$254.9 million, marking a year-over-year decrease of 345.88%. This contributed to the annual value of -$320.7 million for FY2024, which is 9094.74% down from last year.
  • Per P3 Health Partners' latest filing, its EBIT stood at -$320.7 million for FY2024, which was down 9094.74% from -$167.9 million recorded in FY2023.
  • Over the past 5 years, P3 Health Partners' EBIT peaked at -$28.6 million during FY2020, and registered a low of -$1.6 billion during FY2022.
  • Its 5-year average for EBIT is -$441.4 million, with a median of -$167.9 million in 2023.
  • Its EBIT has fluctuated over the past 5 years, first surged by 8924.16% in 2023, then tumbled by 9094.74% in 2024.
  • P3 Health Partners' EBIT (Annual) stood at -$28.6 million in 2020, then plummeted by 351.45% to -$129.1 million in 2021, then crashed by 1109.47% to -$1.6 billion in 2022, then soared by 89.24% to -$167.9 million in 2023, then plummeted by 90.95% to -$320.7 million in 2024.
  • Its EBIT was -$320.7 million in FY2024, compared to -$167.9 million in FY2023 and -$1.6 billion in FY2022.